Atorvastatin Calcium
Product Images NDC 53002-3335

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-3335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing the cumulative incidence percentage over time in years for Atorvastatin versus Placebo. The graph shows two lines, one solid for Atorvastatin and one dashed for Placebo, illustrating lower cumulative incidence for Atorvastatin. A hazard ratio (HR) of 0.64 with confidence interval and p-value is displayed on the graph.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph comparing cumulative hazard (%) over time between Placebo and Atorvastatin. The x-axis measures time to first primary endpoint through 4 years of follow-up, while the y-axis shows cumulative hazard percentage. The graph shows lower cumulative hazard for Atorvastatin compared to Placebo throughout the study period, with a hazard ratio of 0.63 (95% CI 0.48-0.83) and p=0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph depicting the percentage of subjects experiencing a cardiovascular event over five years, comparing Atorvastatin 10 mg (dashed line) versus Atorvastatin 80 mg (solid line). The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of atorvastatin calcium dihydrate, showing its molecular formula with calcium and water of hydration.*

FDA Label Image

Label Image (Lbl530023335)

Atorvastatin Calcium 20mg tablets packaging label from RPK Pharmaceuticals, Inc., showing a 100-tablet bottle. The label includes dosing instruction to take 1 tablet daily as directed, prescription information areas, barcode, and manufacturer details. The label design is black text on a white background with sections for clinic and patient names.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.